Nuveen California Select Tax-Free Income Portfolio
NYSE:NXC
13.1 (USD) • At close December 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3.696 | -5.897 | 3.537 | 5.948 | 4.804 | 4.659 | 4.303 | 4.026 | 4.523 | 4.477 | 4.588 | 4.689 | 0 |
| Cost of Revenue
| 0 | 0.268 | 0.292 | 2.324 | 1.074 | 0.939 | 0.3 | 0.298 | 0.297 | 0 | 0 | 0 | 0 |
| Gross Profit
| 3.696 | -6.165 | 3.245 | 3.623 | 3.73 | 3.72 | 4.003 | 3.728 | 4.226 | 4.477 | 4.588 | 4.689 | 0 |
| Gross Profit Ratio
| 1 | 1.045 | 0.917 | 0.609 | 0.777 | 0.799 | 0.93 | 0.926 | 0.934 | 1 | 1 | 1 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.087 | 0.092 | 0.35 | 0.092 | 0.098 | 0.269 | 0.106 | 0.359 | 0.352 | 0.356 | 0.348 | 0.348 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.087 | 0.092 | 0.35 | 0.092 | 0.098 | 0.269 | 0.106 | 0.359 | 0.352 | 0.356 | 0.348 | 0.348 | 0 |
| Other Expenses
| 0 | -7.57 | -4.636 | 0.002 | 0.002 | 0.003 | 0.003 | 0 | 0.986 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 1.404 | 0.095 | 4.891 | 0.095 | 0.1 | 0.272 | 0.109 | 3.927 | -0.986 | 4.85 | 4.316 | 3.672 | 0 |
| Operating Income
| 2.292 | -5.992 | -1.39 | 3.271 | 3.375 | 3.203 | 4.194 | 0.231 | 5.213 | 4.121 | 4.241 | 4.341 | 0 |
| Operating Income Ratio
| 0.62 | 1.016 | -0.393 | 0.55 | 0.703 | 0.688 | 0.975 | 0.057 | 1.152 | 0.921 | 0.924 | 0.926 | 0 |
| Total Other Income Expenses Net
| 2.806 | -5.724 | -4.541 | 0 | 0 | 0 | 0 | -3.567 | -0 | 0 | -3.975 | 0 | 0 |
| Income Before Tax
| 5.098 | -5.992 | -1.391 | 5.853 | 4.704 | 4.387 | 4.194 | 0.231 | 5.213 | 9.326 | 0.266 | 8.352 | 0 |
| Income Before Tax Ratio
| 1.379 | 1.016 | -0.393 | 0.984 | 0.979 | 0.942 | 0.975 | 0.057 | 1.152 | 2.083 | 0.058 | 1.781 | 0 |
| Income Tax Expense
| 0 | 3.228 | -4.542 | 2.582 | 1.329 | 1.184 | 3.59 | -3.567 | 1.187 | 5.205 | -3.981 | 4.002 | 0 |
| Net Income
| 5.098 | -5.992 | -1.391 | 5.853 | 4.704 | 4.387 | 4.194 | 0.231 | 5.213 | 9.326 | 0.266 | 8.352 | 0 |
| Net Income Ratio
| 1.379 | 1.016 | -0.393 | 0.984 | 0.979 | 0.942 | 0.975 | 0.057 | 1.152 | 2.083 | 0.058 | 1.781 | 0 |
| EPS
| 0.8 | -0.94 | -0.22 | 0.92 | 0.74 | 0.69 | 0.66 | 0.037 | 0.83 | 1.49 | 0.042 | 1.33 | 0 |
| EPS Diluted
| 0.8 | -0.94 | -0.22 | 0.92 | 0.74 | 0.69 | 0.66 | 0.037 | 0.83 | 1.49 | 0.042 | 1.33 | 0 |
| EBITDA
| 5.1 | -5.992 | -1.39 | 2.582 | 1.329 | 1.184 | 0 | -3.567 | 1.187 | 5.205 | -3.975 | 4.011 | 0 |
| EBITDA Ratio
| 1.38 | 1.016 | -0.393 | 0.434 | 0.277 | 0.254 | 0.975 | 0.057 | 1.152 | 1.163 | -0.866 | 0.855 | 0 |